ScreenerHero

MQR MultiQure S.A.

GPW · PL · Healthcare · Biotechnology · multiqure.com
1.612PLN+0.12%Mkt Cap: 92.05M $P/E: —

MultiQure S.A., a biopharmaceutical company, engages in the research and development of biological drugs and medical devices for therapeutic use. Its therapeutic portfolio in the field of immuno-oncology includes PB003G,…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.54BUSDP/E 29.3
MRNA
Moderna, Inc.
$81.13BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$74.79BUSDP/E 18.0
ARGX
argenx SE
$57.11BUSDP/E 34.8
ARGX
argenx SE
$55.24BUSDP/E 36.1
RVMD
Revolution Medicines, Inc.
$44.51BUSD
UCB
UCB SA
$41.63BUSDP/E 17.7
ONC
BeOne Medicines AG
$41.14BUSDP/E 64.7
RPRX
Royalty Pharma plc
$32.74BUSDP/E 30.1
ALNY
Alnylam Pharmaceuticals, Inc.
$29.42BUSDP/E 37.1
ROIV
Roivant Sciences Ltd.
$25.84BUSD
BNTX
BioNTech SE
$24.53BUSD
GMAB
Genmab A/S
$24.01BUSDP/E 30.3
INCY
Incyte Corporation
$23.13BUSDP/E 14.5
INSM
Insmed Incorporated
$22.67BUSD
GMAB
Genmab A/S
$21.61BUSDP/E 29.3
JAZZ
Jazz Pharmaceuticals plc
$15.32BUSDP/E 16.2
ASND
Ascendis Pharma A/S
$15.01BUSDP/E 17.5
EXEL
Exelixis, Inc.
$14.58BUSDP/E 18.6
SMMT
Summit Therapeutics Inc.
$13.78BUSD

Key Statistics

Company
Market Cap92.05M USD
Enterprise Value8.90M USD
Revenue (TTM)—
Gross Profit-7.34K USD
Net Income (TTM)-2.49M USD
Revenue/Share—
Last Price1.612 PLN
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLPRBLG00010
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-5.39
EV/Revenue—
P/S—
P/B-1.20
EPS (TTM)-1.37
EPS (Forward)—
52W Range
1.3534% of range7.770
52W High7.770 PLN
52W Low1.353 PLN
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE69.41%
ROA-198.79%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.58M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-1.14%
Net Debt3.91M USD
Net Debt/EBITDA-2.36
Balance Sheet
Debt/Equity-1.13
Current Ratio0.09
Quick Ratio0.08
Book Value/Sh-1.34 PLN
Cash/Share0.08 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 PLN
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.225.75M
Float10.70M
Insiders72.43%
Institutions18.63%
Technical
SMA 502.417 (-33.3%)
SMA 2002.658 (-39.3%)
Beta0.27
S&P 52W Chg14.58%
Avg Vol (30d)345.83K
Avg Vol (10d)628.80K
Technical Indicators
RSI (14)27.2
MACD-0.2291
MACD Signal-0.0537
MACD Hist.-0.1754
BB Upper3.858 PLN
BB Middle2.627 PLN
BB Lower1.396 PLN
BB Width93.71%
ATR (14)0.2082 PLN
Vol Ratio (20d)0.86x